New medication may enhance the effect of pancreatic cancer chemotherapyOne of the major obstacles in the treatment of pancreatic cancer is the ‘defense wall’ that is formed around the tumor. This ‘desmoplastic stroma’ prevents chemotherapy from reaching the tumor. Scientists of the University of Twente now found out which part of the stroma can best be attacked. Furthermore, they discovered a new peptide that can serve as the attacker. In ‘Science Advances’ of 4 September, they show that using the combination of the peptide and cytostatics, tumor volume can be drastically reduced. In four to five years, the combination therapy may be available for patient tests.Read more
ERC Starting Grant for two promising UT scientistsThe ERC Starting Grants provided by the European Research Council, may well kickstart a young promising researcher’s career. Two University of Twente researchers were awarded a Starting Grant, the Council announced today: David Fernandez Rivas and Monica Morales-Masis, both affiliated with the University of Twente’s MESA+ Institute, will receive a financial contribution of 1,5 million euro and 1,75 million euro to develop new meaningful technologies.Read more
New medication may enhance the effect of pancreatic cancer chemotherapy
ERC Starting Grant for two promising UT scientists
New UT spinoff in medical robotics
Breast cancer app developed by ZGT and UT nominated for care award: Vote now
University of Twente’s TechMed Centre appoints new medical director
Multi-modal analysis platform for capturing tumor-derived extracellular vesicles
Mulholland Memorial Award for Srinivas Vanapalli
LipoCoat announced as European Biotech Startup of the year
Demonstrating the potential of 'organ-on-chip'
Survey: healthcare professionals expect major changes because of the rise of AI in healthcare
Virtual activity coach for overweight people should enhance self-confidence
Joeke Nollet awarded 2019 Marina van Damme Scholarship
